Associated Papers
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.
Liu D et al.
Cancer Research Communications, 2025
40178042 (PubMed )
Supplement: crc-24-0620_supplementary_figure_s9_suppsf9.pdf
Select a paper to view details